NCT07304518: Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
- State
- Under way
- Phase
- Phase 2
- People
- 456 planned
- Started
- 26 Jan 2026
- Primary completion
- Sep 2026
- Arms
- PRT-064040 nasal spray (dose 1), PRT-064040 nasal spray (dose 2), PRT-064040 nasal spray (dose 3)
- Results
- None posted
- 26 Dec 2025: Trial registered
- 26 Jan 2026: Trial started